Company Overview and News
An anti-cigarette smuggling task force uncovered smuggled and fake cigarettes worth about P80 million in Malabon and Manila last week amid higher prices of the so-called sin product due to the government’s first tax reform package, the two leading tobacco manufacturers said.
The government, along with businesses, marked the first business day of fiscal 2018 on Monday, with the former pledging revival after being hit by scandals while some food and beverage producers hiked prices due to increasing personnel and raw material expenses.
REDWOOD CITY, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ:MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant, for the treatment of pruritus associated with various underlying dermatologic conditions and for refractory chronic cough, today announced financial results for the fourth quarter and year ended December 31, 2017 and provided an update on its clinical development programs.
He may be a wanted man in Greece, but fans of the Thessaloniki-based PAOK soccer team love its owner, Ivan Savvidis, who’s in hiding after taking a gun onto the field while protesting a goal waved off against rival AEK of Athens.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Foreign Direct Investments (FDI) recorded an all-time high in President Rodrigo R. Duterte’s first full year in office, reaching $10 billion in 2017 and surpassing the government’s $8 billion target. The 2017 figures came on the heels of the widely circulated US News & World Report, which cited the Philippines as one of the top countries to invest in, even outranking our neighbors such as Indonesia, Malaysia, and Singapore.
Thessaloniki (Greece) (AFP) - A Greek-Russian businessman of humble origins, PAOK FC owner Ivan Savvidis has put Greek football once again under the spotlight after storming onto the pitch with a holstered gun at his belt.
Japan Tobacco has agreed to buy Donskoy Tabak, Russia's fourth-largest cigarette maker, for $1.6 billion (90 billion roubles) in a bid to reinforce its leading position in the country.
SEKAP, the Greek Cooperative Tobacco Industry that was owned by Donskoy Tabak since 2013, will pass to Japanese ownership as part of a larger package deal worth around 1.6 billion dollars that was signed on Friday.
GENEVA – Japan Tobacco Inc. has agreed to buy Russia’s Donskoy Tabak for 90 billion rubles ($1.6 billion), strengthening its leading position in Russia as competition from cigarette alternatives erodes its domestic market share.
Japan Tobacco has agreed to buy Russia's Donskoy Tabak for about 90 billion roubles ($1.56 billion) to strengthen its leading position in the world's third-largest tobacco market.
FOREIGN direct investments (FDIs) in Philippine manufacturing will grow by a “reasonable” 10-15% in 2018 as investors remain bullish on the economy’s prospects, though this year’s pace will be a marked slowdown from 2017’s surge, the Department of Trade and Industry (DTI) said on Wednesday.
The government’s Tax Reform for Acceleration and Inclusion (TRAIN) began to make an impact on inflation this January and February, with a spike of 3.9% under the revised series. In line with international practice, the consumer price index (CPI) series is rebased periodically by the Philippine Statistics Authority to ensure that the prices in the basket of goods being measured stay relevant and representative.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET